Recruiting PHASE3 Smoking Cessation

Clinical trial for Smoking Cessation

Official title Studying NMDA and Sigma-1 in Smoking Cessation Treatment (SUMMIT)

ClinicalTrials.gov ID: NCT07766655

What this study is testing

What is AXS-05 (dextromethorphan-bupropion)?

AXS-05 (dextromethorphan-bupropion) is an investigational medicine, given as an once-daily pill taken by mouth, being studied as a potential treatment for smoking cessation.

Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.

What it's testing
This study is a Phase 3, multicenter, randomized, double-blind, placebo- and active-controlled, parallel-group trial to evaluate the efficacy and safety of AXS-05 compared to placebo and bupropion for smoking cessation in adults.
  • Phase 3: a large, late-stage study
  • You might receive a placebo (an inactive treatment) instead of the study drug, decided by chance. You may not know which one you got.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 18 to 65

You may be able to join if

  • Male or female, aged 18 to 65 (inclusive)

You likely can't join if

  • Unable to comply with study procedures.
  • Medically inappropriate for study participation in the opinion of the investigator.

The study team makes the final eligibility decision.

Where it's taking place

  • Little Rock, Arkansas, United States
  • Lemon Grove, California, United States
  • Pomona, California, United States
  • DeLand, Florida, United States
  • Jacksonville, Florida, United States
  • Orlando, Florida, United States
  • Stockbridge, Georgia, United States
  • Skokie, Illinois, United States
  • Evansville, Indiana, United States
  • Kansas City, Missouri, United States
  • Brooklyn, New York, United States
  • Knoxville, Tennessee, United States
  • Memphis, Tennessee, United States
  • Austin, Texas, United States
  • Fort Worth, Texas, United States
  • Newport News, Virginia, United States

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 18 years to 65 years. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Little Rock, Arkansas, United States; Lemon Grove, California, United States; Pomona, California, United States; DeLand, Florida, United States; Jacksonville, Florida, United States; Orlando, Florida, United States and 10 more location(s). Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.